Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Estradiol implant | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has active ingredient | Estradiol | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Prolonged-release subcutaneous implant | true | Inferred relationship | Some | ||
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength numerator value | 25 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has precise active ingredient | Estradiol | true | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has unit of presentation | Implant (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has basis of strength substance (attribute) | Estradiol | true | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength denominator unit (attribute) | Implant (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Product containing only estradiol in subcutaneous dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Estradiol only product in parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR